Follow the Calcium—Influx Through NMDARs Releases Yet More From ER
underlie the onset age heterogeneity (Nelson et al., 2010).—Esther Landhuis None
373 RESULTS
You searched Landhuis
Sort By:
underlie the onset age heterogeneity (Nelson et al., 2010).—Esther Landhuis None
Dementia Treatment Study Group. To learn all about that, see Part 2 and Part 3.—Esther Landhuis. This is
May 24.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=2794 Alzheimer's Disease
similar results as the current genetic knockout approach.—Esther Landhuis None
Landhuis None http://www.alzforum.org/new/detail.asp?id=2017 Cerebral Amyloid Angiopathy Immune Related
developments, read Part 2.—Esther Landhuis. This is Part 1 of a four-part series. See also Part 2, Part 3, Part
long-term memory.—Esther Landhuis This is Part 2 of a three-part series. See also Part 1 and Part 3.
hypothesis of AD’ are much more closely related than it initially appeared.”—Esther Landhuis None
roles in lysosomal degradative functions relevant to AD pathogenesis,” he wrote.—Esther Landhuis None
author of an in-press review on omega-3 fatty acids and dementia (Cole et al., 2009).—Esther Landhuis
weekly intravenous infusions.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=3099
correlates with increased risk of AD and vascular dementia 30 years later.—Esther Landhuis None
comments by Valerie Cullen, Joseph Mazzulli, and Dimitri Krainc below).—Esther Landhuis None
recruiting for a Phase 2 trial of its γ-secretase inhibitor BMS-708163 in prodromal AD.—Esther Landhuis None
350,000 chemical compounds.—Esther Landhuis None http://www.alzforum.org/new/detail.asp?id=2947